DE69710909D1 - Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel - Google Patents

Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Info

Publication number
DE69710909D1
DE69710909D1 DE69710909T DE69710909T DE69710909D1 DE 69710909 D1 DE69710909 D1 DE 69710909D1 DE 69710909 T DE69710909 T DE 69710909T DE 69710909 T DE69710909 T DE 69710909T DE 69710909 D1 DE69710909 D1 DE 69710909D1
Authority
DE
Germany
Prior art keywords
production
products containing
medicinal products
tetrahydropyridine derivatives
substituted tetrahydropyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69710909T
Other languages
English (en)
Other versions
DE69710909T2 (de
Inventor
Christian Marazano
Delphine Compere
Bhupesh Das
Jean Lepagnol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE69710909D1 publication Critical patent/DE69710909D1/de
Publication of DE69710909T2 publication Critical patent/DE69710909T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69710909T 1996-12-05 1997-12-02 Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel Expired - Fee Related DE69710909T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614951A FR2756826B1 (fr) 1996-12-05 1996-12-05 Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1997/002172 WO1998024765A1 (fr) 1996-12-05 1997-12-02 Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69710909D1 true DE69710909D1 (de) 2002-04-11
DE69710909T2 DE69710909T2 (de) 2002-11-07

Family

ID=9498371

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69710909T Expired - Fee Related DE69710909T2 (de) 1996-12-05 1997-12-02 Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Country Status (19)

Country Link
US (1) US6232319B1 (de)
EP (1) EP0937043B1 (de)
JP (1) JP3872821B2 (de)
CN (1) CN1126739C (de)
AT (1) ATE214051T1 (de)
AU (1) AU719208B2 (de)
CA (1) CA2274133C (de)
DE (1) DE69710909T2 (de)
DK (1) DK0937043T3 (de)
ES (1) ES2172023T3 (de)
FR (1) FR2756826B1 (de)
HK (1) HK1023346A1 (de)
HU (1) HUP0001773A3 (de)
NO (1) NO313589B1 (de)
NZ (1) NZ336111A (de)
PL (1) PL189372B1 (de)
PT (1) PT937043E (de)
WO (1) WO1998024765A1 (de)
ZA (1) ZA9710960B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793245B1 (fr) * 1999-05-05 2002-10-11 Adir Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
ATE378048T1 (de) * 2002-12-06 2007-11-15 The Feinstein Inst Medical Res Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
US7238715B2 (en) * 2002-12-06 2007-07-03 The Feinstein Institute For Medical Research Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
US8316104B2 (en) 2005-11-15 2012-11-20 California Institute Of Technology Method and apparatus for collaborative system
KR20180011888A (ko) 2008-11-19 2018-02-02 포럼 파마슈티칼즈 인크. (ｒ)-７-클로로-ｎ-(퀴누클리딘-３-일)벤조［ｂ］티오펜-２-카르복사미드 및 그 약학적으로 허용가능한 염을 이용한 인지 장애의 치료
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
BRPI1014793A2 (pt) * 2009-05-11 2016-04-05 Envivo Pharmaceuticals Inc tratamento de distúrbios de cognição com determinados receptores de ácido alfa-7-nicotínico em combinação com inibidores de acetil-colinesterase
RS54742B1 (sr) 2010-05-17 2016-10-31 Forum Pharmaceuticals Inc Kristalni oblik (r)-7-hlor-n-(hinuklidin-3-il)benzo[b]tiofen-2-karboksamid hidrohlorid monohidrata
WO2013169646A1 (en) 2012-05-08 2013-11-14 Envivo Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function

Also Published As

Publication number Publication date
JP3872821B2 (ja) 2007-01-24
US6232319B1 (en) 2001-05-15
FR2756826A1 (fr) 1998-06-12
ATE214051T1 (de) 2002-03-15
ZA9710960B (en) 1998-06-15
AU7624398A (en) 1998-06-29
JP2001505214A (ja) 2001-04-17
CA2274133C (fr) 2003-09-16
FR2756826B1 (fr) 1999-01-08
AU719208B2 (en) 2000-05-04
CN1126739C (zh) 2003-11-05
HK1023346A1 (en) 2000-09-08
NO992731L (no) 1999-06-04
NZ336111A (en) 2000-03-27
EP0937043B1 (de) 2002-03-06
HUP0001773A3 (en) 2002-12-28
PL189372B1 (pl) 2005-07-29
DE69710909T2 (de) 2002-11-07
EP0937043A1 (de) 1999-08-25
NO992731D0 (no) 1999-06-04
PT937043E (pt) 2002-07-31
CA2274133A1 (fr) 1998-06-11
CN1239951A (zh) 1999-12-29
HUP0001773A2 (hu) 2000-11-28
WO1998024765A1 (fr) 1998-06-11
DK0937043T3 (da) 2002-06-10
ES2172023T3 (es) 2002-09-16
NO313589B1 (no) 2002-10-28

Similar Documents

Publication Publication Date Title
ATE128458T1 (de) Naphtylalkylamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE124047T1 (de) Oxazolopyridinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
ATE229017T1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
ATE174920T1 (de) Pyridothiadiazine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE13056T1 (de) Indanderivate, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
ATE156829T1 (de) Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE69710909D1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATE160338T1 (de) Alpha aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE197706T1 (de) Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
DE69837045D1 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren, ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
FI954931A0 (fi) Uusia piperidinyylitioindolin johdannaisia, niiden valmistusmenetelmä, niitä sisältäviä farmaseuttisia koostumuksia, jotka ovat käyttökelpoisia erityisesti kivun lievittäjinä
ATE125538T1 (de) Thiochromanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE140213T1 (de) N-monosubstituierte cyclopentenylamine, ein verfahren zu ihrer herstellung, und ihre verwendung als medikament
ATE144510T1 (de) N-(isochinolein-5-yl)-sulfonyl azazykloalkane, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE68906519D1 (de) Aryloxypropanolaminotetraline, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel.
ATE123776T1 (de) Aminoalkylchromone, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
DE68906049D1 (de) Benzocyclohexan- und benzocycloheptan-derivate und deren salze, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als heilmittel und diese enthaltende zusammensetzungen.
ATE28647T1 (de) Chinazolinonderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE140216T1 (de) (cyclohexyl)alkenderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
ATE173734T1 (de) Heteroarenylpiperazine, verfahren zu ihrer herstellung und ihre anwendung als medikamente

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee